Indiana Healthcare Today
SEE OTHER BRANDS

Get your fresh news on health and wellness in Indiana

Indiana Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Indiana Healthcare Today.

Press releases published on June 25, 2025

Rakovina Therapeutics Announces Results from 2025 Annual General Meeting

Rakovina Therapeutics Announces Results from 2025 Annual General Meeting

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)- …

Hapbee Announces CDN$1.5M Private Placement Led by Company Executive; Announces Appointment of Ahsan Ashraf as Chief Technology Officer

Hapbee Announces CDN$1.5M Private Placement Led by Company Executive; Announces Appointment of Ahsan Ashraf as Chief Technology Officer

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company, is pleased to announce a non-brokered private placement …

PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares

PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares

TORONTO, June 25, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being, is pleased to announce an update to its …

Vor Bio Announces $175 Million Private Placement

Vor Bio Announces $175 Million Private Placement

CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it has entered into a securities purchase agreement for a private …

Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset

Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset

-Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis -RemeGen receives initial payment of $125 million …

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025

TEL AVIV, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2025 financial results on Wednesday, July 30, 2025, at 7:00 a.m. ET. …

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide.

DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide.

Châtillon, France, le 25 juin (22 :30 CEST) 2025 DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide. Screening du premier sujet à l' …

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old

DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old

Châtillon, France, June 25, 2025 DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old First subject screened at the Respiratory Medicine Research Institute of Michigan …

Option Care Health to Announce Second Quarter 2025 Financial Results and Host Conference Call

Option Care Health to Announce Second Quarter 2025 Financial Results and Host Conference Call

BANNOCKBURN, Ill., June 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release …

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Rajesh “Raj” Asarpota has been appointed …

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that it will host an R…

Neurosculpting Institute Announces Peer-Reviewed Study Linking Neurosculpting Meditation to Improved Clinical Accuracy in Dental Students

Neurosculpting Institute Announces Peer-Reviewed Study Linking Neurosculpting Meditation to Improved Clinical Accuracy in Dental Students

Denver, CO , June 25, 2025 (GLOBE NEWSWIRE) -- The Neurosculpting® Institute, a meditation and neuroplasticity education organization, announced the publication of a peer-reviewed study in the Cureus Journal of Medical Science showing that undergraduate …

CHESS Health Rewards Engine: A Better Way to Fight Stimulant Crisis Across Colorado

CHESS Health Rewards Engine: A Better Way to Fight Stimulant Crisis Across Colorado

Rochester, New York, June 25, 2025 (GLOBE NEWSWIRE) -- CHESS Health is partnering with Porch Light HealthⓇ (PLH) to offer its innovative, automated contingency management Rewards Engine for treating individuals with substance use disorder (SUD). PLH’s …

Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial

Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial

HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Gold H2, a climate tech energy company, today announced the successful completion of the world’s first field trial demonstrating subsurface bio-stimulated hydrogen production. Conducted in a legacy oilfield in …

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance

Saint-Herblain (France), June 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Annual General …

Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale annuelle et confirme ses perspectives financières 2025

Valneva annonce l’approbation des résolutions présentées à son Assemblée Générale annuelle et confirme ses perspectives financières 2025

Saint-Herblain (France), le 25 juin 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que toutes les résolutions recommandées par son conseil d’administration ont été approuvées par les …

Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets

Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets

CHICAGO, June 25, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed announces an expansion of his COVID-19 testing services, with new COVID testing contracts now secured and under negotiation across the United States and in key international markets. The initiative …

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fireside discussion …

Ernst & Young Names USOSM’s Richard Hall an Entrepreneur Of The Year 2025 Southwest Award Winner

Ernst & Young Names USOSM’s Richard Hall an Entrepreneur Of The Year 2025 Southwest Award Winner

IRVING, Texas, June 25, 2025 (GLOBE NEWSWIRE) -- Ernst …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service